Influence of Neurologic Manifestations of Primary Human Immunodeficiency Virus Infection on Disease Progression

Authors:
  • SGSEROCO Study Group
    SEROCO Study Group

Abstract
To determine the influence of neurologic manifestations of primary human immunodeficiency virus (HIV) infection on disease progression, 277 nonhemophiliac adults enrolled n = 23), with nonneurologic manifestations (group N−; n = 112) during PSI, and without any clinical manifestation during primary infection (group NPI; n = 142) were compared for disease progression, Age at infection, sex, mode of infection and CD4+ cell count at first visit did not differ between groups, In a Cox model, the relative risk (RR) of developing AIDS was 6.11 (95% confidence interval [CI], 1.94–19.28) in group N+ and 2.32 (95% CI, 0.93–5.83) in group N− compared with group NPI. The RR of AIDS onset after adjustment for treatment and age at infection was, respectively, 4.65 (95% CI, 1.43–15.03) and 2.03 (95% CI, 0.80–5.19) in groups N+ and N−. Neurologic manifestations of primary HIV infection are associated with an accelerated progression of disease.